Long-acting methylphenidate for the treatment of adults with attention deficit hyperactivity disorder

被引：0
|
作者：
Asherson, P
Libretto, SE
机构：
[1] Janssen Cilag Ltd, High Wycombe HP14 4HJ, Bucks, England
[2] Inst Psychiat, MRC, Social Genet Dev Psychiat Ctr, London SE5 8AF, England
来源：
BRITISH JOURNAL OF DEVELOPMENTAL DISABILITIES | 2004年 / 50卷 / 99期
关键词：
D O I：
暂无
中图分类号：
G76 [特殊教育];
学科分类号：
040109 ;
摘要：
引用
收藏
页码：143 / 151
页数：9
相关论文
共 50 条
  • [41] Methylphenidate for attention-deficit/hyperactivity disorder in adults: a narrative review
    Jaeschke, Rafal R.
    Sujkowska, Ewelina
    Sowa-Kucma, Magdalena
    PSYCHOPHARMACOLOGY, 2021, 238 (10) : 2667 - 2691
  • [42] The Safety and Efficacy of Methylphenidate and Dexmethylphenidate in Adults with Attention Deficit/Hyperactivity Disorder
    Sopko, Michael A., Jr.
    Caberwal, Harjeet
    Chavez, Benjamin
    JOURNAL OF CENTRAL NERVOUS SYSTEM DISEASE, 2010, 2 : 15 - 30
  • [43] Methylphenidate for Attention-Deficit/Hyperactivity Disorder
    Romanos, Marcel
    Reif, Andreas
    Banaschewski, Tobias
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2016, 316 (09): : 994 - 995
  • [44] Methylphenidate in attention deficit hyperactivity disorder and bipolar disorder
    Kummer, Arthur
    Teixeira, Antonio
    AUSTRALASIAN PSYCHIATRY, 2008, 16 (06) : 458 - 459
  • [45] USE OF METHYLPHENIDATE FOR ATTENTION DEFICIT HYPERACTIVITY DISORDER
    不详
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 1990, 142 (08) : 817 - 818
  • [46] Attention deficit and hyperactivity disorder, methylphenidate, and epilepsy
    Tan, M
    Appleton, R
    ARCHIVES OF DISEASE IN CHILDHOOD, 2005, 90 (01) : 57 - 59
  • [47] Methylphenidate and attention-deficit hyperactivity disorder
    Mellis, Craig
    JOURNAL OF PAEDIATRICS AND CHILD HEALTH, 2016, 52 (03) : 354 - 355
  • [48] Innovations in attention-deficit/hyperactivity disorder pharmacotherapy: Long-acting stimulant and nonstimulant treatments
    Stein, MA
    AMERICAN JOURNAL OF MANAGED CARE, 2004, 10 (04): : S89 - S98
  • [49] Comparative treatment patterns, healthcare resource utilization and costs of atomoxetine and long-acting methylphenidate among children and adolescents with attention-deficit/hyperactivity disorder in Germany
    Peter Greven
    Vanja Sikirica
    Yaozhu J. Chen
    Tammy G. Curtice
    Charles Makin
    The European Journal of Health Economics, 2017, 18 : 893 - 904
  • [50] Long-acting methylphenidate formulations in the treatment of attention-deficit/hyperactivity disorder: a systematic review of head-to-head studies (vol 13, 237, 2013)
    Coghill, David
    Banaschewski, Tobias
    Zuddas, Alessandro
    Pelaz, Antonio
    Gagliano, Antonella
    Doepfner, Manfred
    BMC PSYCHIATRY, 2015, 15
12345